EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
EHRA EUROPACE 2013 - European Society of Cardiology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
tUEsdAy<br />
sEssiOns<br />
tuesday 25 June <strong>2013</strong> - morning<br />
12:45 - 13:45 satellite symposium lefkada<br />
Novel oral anticoagulants during clinical procedures in patients with AF:<br />
translating promising data into real-life practice<br />
sponsored by boehringer ingelheim<br />
Chairpersons: G.y.H. lip (birmingham, Gb); P.E. Vardas (Heraklion, GR)<br />
To describe the available guidance (specifically the <strong>EHRA</strong> guidance) and data supporting optimal<br />
strategies for using NOACs in patients with AF undergoing clinical procedures, focussing on<br />
cardioversion and ablation. To discuss the practicalities <strong>of</strong> using NOACs in patients undergoing invasive<br />
procedures. To use real-world information to provide insights into optimal management strategies.<br />
12:45 introduction and welcome. 813<br />
G.Y.H. Lip (Birmingham, GB)<br />
12:50 <strong>EHRA</strong> guidance for patients undergoing procedures: a useful tool for real-life practice. 814<br />
H. Heidbuchel (Leuven, BE)<br />
13:00 Protecting patients during ablation: what is the optimal anticoagulation strategy? 815<br />
S.H. Hohnloser (Frankfurt, DE)<br />
13:20 safeguarding patients undergoing cardioversion: optimizing your approach to<br />
anticoagulation. 816<br />
G.K. Andrikopoulos (Thrakomakedones-Athens, GR)<br />
13:40 summary and close. 817<br />
P.E. Vardas (Heraklion, GR)<br />
12:45 - 13:45 satellite symposium Kythira<br />
A new paradigm in ICD therapy: clinical perspectives on a novel singlechamber<br />
ICD system with complete atrial diagnostics<br />
sponsored by biOtROniK<br />
Chairperson: b. Merkely (budapest, HU)<br />
By the end <strong>of</strong> the symposium, the participants should be able to: Discuss the clinical benefits <strong>of</strong> this new<br />
ICD system and specifically <strong>of</strong> its single-coil, single-pass ICD lead with atrial sensing capability. Describe<br />
the particular benefit <strong>of</strong> the atrial sensing capability for early detection <strong>of</strong> atrial fibrillation when used<br />
with BIOTRONIK Home Monitoring.<br />
12:45 introduction. 818<br />
B. Merkely (Budapest, HU)<br />
12:55 Clinical value <strong>of</strong> atrial electrogram in a single-lead ICD? 819<br />
C. Sticherling (Basel, CH)<br />
13:20 Home Monitoring: advantages <strong>of</strong> early detection <strong>of</strong> atrial fibrillation in ICD patients. 820<br />
D. Bansch (Hamburg, DE)<br />
13:40 summary and conclusions. 821<br />
B. Merkely (Budapest, HU)<br />
122